In non‐small cell lung cancer (NSCLC), especially in adenocarcinoma, “driver mutations” have been discovered in genes such as EGFR (epidermal growth factor receptor), which are important to the processes of cancerization and proliferation.3, 4, 5. Here, EGFR is linked to non-small cell lung carcinoma.